CME Cme Group Inc

Price (delayed)

$277.74

Market cap

$100.09B

P/E Ratio

26.83

Dividend/share

$10.6

EPS

$10.35

Enterprise value

$243.69B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
The company's net income rose by 14% YoY and by 3.9% QoQ
The EPS is up by 14% year-on-year and by 3.8% since the previous quarter
The debt has surged by 63% year-on-year and by 17% since the previous quarter
CME's P/E is 7% above its last 4 quarters average of 25.1

Key stats

What are the main financial stats of CME
Market
Shares outstanding
360.38M
Market cap
$100.09B
Enterprise value
$243.69B
Valuations
Price to earnings (P/E)
26.83
Price to book (P/B)
3.61
Price to sales (P/S)
15.5
EV/EBIT
49.05
EV/EBITDA
45.97
EV/Sales
37.82
Earnings
Revenue
$6.44B
Gross profit
$6.44B
Operating income
$4.21B
Net income
$3.72B
EBIT
$4.97B
EBITDA
$5.3B
Free cash flow
$4.11B
Per share
EPS
$10.35
EPS diluted
$10.33
Free cash flow per share
$11.42
Book value per share
$76.98
Revenue per share
$17.92
TBVPS
$415.62
Balance sheet
Total assets
$179.91B
Total liabilities
$152.17B
Debt
$145.58B
Equity
$27.74B
Working capital
$2.66B
Liquidity
Debt to equity
5.25
Current ratio
1.02
Quick ratio
1.01
Net debt/EBITDA
27.09
Margins
EBITDA margin
82.3%
Gross margin
100%
Net margin
57.7%
Operating margin
65.3%
Efficiency
Return on assets
2.4%
Return on equity
13.6%
Return on invested capital
4.1%
Return on capital employed
13.4%
Return on sales
77.1%
Dividend
Dividend yield
3.82%
DPS
$10.6
Payout ratio
102.4%

CME stock price

How has the Cme Group stock price performed over time
Intraday
1.14%
1 week
0.46%
1 month
0.77%
1 year
40.84%
YTD
19.6%
QTD
0.77%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$6.44B
Gross profit
$6.44B
Operating income
$4.21B
Net income
$3.72B
Gross margin
100%
Net margin
57.7%
The operating income is up by 16% YoY and by 3.2% QoQ
The company's net income rose by 14% YoY and by 3.9% QoQ
The gross profit has increased by 11% YoY and by 2.5% from the previous quarter
CME's revenue is up by 11% year-on-year and by 2.5% since the previous quarter

Price vs fundamentals

How does CME's price correlate with its fundamentals

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
26.83
P/B
3.61
P/S
15.5
EV/EBIT
49.05
EV/EBITDA
45.97
EV/Sales
37.82
The EPS is up by 14% year-on-year and by 3.8% since the previous quarter
CME's P/E is 7% above its last 4 quarters average of 25.1
CME's price to book (P/B) is 34% higher than its 5-year quarterly average of 2.7 and 9% higher than its last 4 quarters average of 3.3
The equity has grown by 2.6% since the previous quarter
CME's revenue is up by 11% year-on-year and by 2.5% since the previous quarter
The P/S is 9% higher than the 5-year quarterly average of 14.2 and 8% higher than the last 4 quarters average of 14.3

Efficiency

How efficient is Cme Group business performance
Cme Group's return on equity has increased by 14% YoY and by 3.8% QoQ
The ROIC has contracted by 9% YoY and by 7% from the previous quarter
Cme Group's return on assets has decreased by 8% QoQ and by 8% YoY
The return on sales is up by 2.4% year-on-year

Dividends

What is CME's dividend history
DPS
$10.6
Dividend yield
3.82%
Payout ratio
102.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 18% more than its total liabilities
Cme Group's total liabilities has surged by 59% YoY and by 16% QoQ
Cme Group's total assets has increased by 46% YoY and by 14% from the previous quarter
The debt to equity has soared by 63% YoY and by 14% from the previous quarter
The debt has surged by 63% year-on-year and by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.